Vimarsana
Biggest News Aggregation in the World

Surrendra Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Surrendra Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Surrendra Group Today - Breaking & Trending Today

The Tea Market to grow by USD 20.5 billion from 2022 to 2027 | New product launches to boost market growth - Vimarsana News

The Tea Market to grow by USD 20.5 billion from 2022 to 2027 | New product launches to boost market growth

/PRNewswire/ -- The tea market is estimated to grow by USD 20.5 billion from 2022 to 2027, growing at a CAGR of 5.55%, according to Technavio. APAC is...

Tea Market Size to Grow by USD 19.48 Bn, New Product Launches to Drive Growth - Vimarsana News

Tea Market Size to Grow by USD 19.48 Bn, New Product Launches to Drive Growth

/PRNewswire/ -- The tea market will be driven by factors such as new product launches. The preference of consumers is shifting from regular tea products to...

Herbal Tea Market Size Worth USD 5,445.22 million, Globally, by 2029 at 6.50% CAGR : Data Bridge Market Research - Vimarsana News

Herbal Tea Market Size Worth USD 5,445.22 million, Globally, by 2029 at 6.50% CAGR : Data Bridge Market Research

Herbal Tea Market has gained momentum in recent times because of the increase in awareness of nutritional food consumption and healthcare.

Martin & Harris Labs reports robust results in FY21, PAT zooms 139 per cent to Rs 177 Cr - Vimarsana News

Martin & Harris Labs reports robust results in FY21, PAT zooms 139 per cent to Rs 177 Cr

New Delhi [India], January 15 (ANI/PNN): Martin & Harris Laboratories, the pharmaceutical arm of Apeejay Group, has announced its results for the financial year ended on March 31, 2021.

Martin Harris Labs reports robust results in FY21, PAT zooms 139 per cent to Rs 177 Cr - Vimarsana News

Martin Harris Labs reports robust results in FY21, PAT zooms 139 per cent to Rs 177 Cr

Martinamp;Harris Laboratories, the pharmaceutical arm of Apeejay Group, has announced its results for the financial year ended on March 31, 2021.